AC Immune stock jumps 20 percent on data for Parkinsons disease drug - MSN
| ACIU Stock | USD 2.74 0.06 2.24% |
Slightly above 55% of AC Immune's private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding AC Immune suggests that some traders are interested. AC Immune's investing sentiment can be driven by a variety of factors including economic data, AC Immune's earnings reports, geopolitical events, and overall market trends.
ACIU |
AC Immune stock jumps 20 percent on data for Parkinsons disease drug MSN
Read at news.google.com
 |
AC Immune Fundamental Analysis
We analyze AC Immune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AC Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AC Immune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
AC Immune is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
AC Immune Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AC Immune stock to make a market-neutral strategy. Peer analysis of AC Immune could also be used in its relative valuation, which is a method of valuing AC Immune by comparing valuation metrics with similar companies.
Peers
AC Immune Related Equities
| IVVD | Invivyd | 16.67 | ||||
| MNOV | MediciNova | 5.35 | ||||
| PEPG | PepGen | 4.96 | ||||
| ANTX | AN2 Therapeutics | 4.67 | ||||
| FDMT | 4D Molecular | 3.39 | ||||
| SYBX | Synlogic | 2.94 | ||||
| ABEO | Abeona Therapeutics | 1.52 | ||||
| BDTX | Black Diamond | 1.28 | ||||
| ACRV | Acrivon Therapeutics, | 1.12 | ||||
| OPT | Opthea | 0.97 | ||||
| STOK | Stoke Therapeutics | 0.47 | ||||
| RGNX | Regenxbio | 0.27 | ||||
| AVTE | Aerovate Therapeutics | 0.41 | ||||
| PHVS | Pharvaris | 0.58 | ||||
| PMVP | Pmv Pharmaceuticals | 2.11 | ||||
| ANEB | Anebulo Pharmaceuticals | 7.64 |
Additional Tools for ACIU Stock Analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.